Hangzhou Minsheng Binjiang Pharma (HMBP) is wholly-owned by Minsheng Pharma (founded in 1926). It obtained US FDA approval in 2011 & 2014 for solid dosage forms. The plant owns one blister line and one bottle line and focuses on generics for regulated markets.

Based on APIs and focused on preparations, the company produces and develops products of high-tech. It produces active pharmaceutical ingredients and four categories of drug formulations . All of the products and facilities have GMP certificates issued by SDA(State Drug Administration).

Sales Markets

North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity


Contact information




View All Contact Info

Top Products

 Amiloride Hcl

Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.

1-Sulfomethyl-5-Mercaptotetrazole Disodium Salt

Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.

Categories affiliated with Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.